Markets:

Overview

News

Currencies

International

Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

3.390 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

38 39 Next >

Cassava Sciences Announces Closing of $50 Million Registered Direct Offering

November 22, 2022

From Cassava Sciences, Inc.

Via GlobeNewswire

Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock

November 18, 2022

From Cassava Sciences, Inc.

Via GlobeNewswire

7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022 ↗

November 16, 2022

After getting knocked down by controversy this year, can any of these seven corporate scandal stocks make a recovery?

Via InvestorPlace

$100 Invested In Cassava Sciences 20 Years Ago Would Be Worth This Much Today ↗

November 16, 2022

Via Benzinga

Cassava Sciences: Q3 Earnings Insights ↗

November 07, 2022

Cassava Sciences (NASDAQ:SAVA) reported its Q3 earnings results on Monday, November 7, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Is Cassava Sciences (SAVA) Stock Up Today? ↗

November 14, 2022

Today's big move in Cassava Sciences and SAVA stock has many investors watching this company's trials closer than ever.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 14, 2022

Gainers

Via Benzinga

CASSAVA SCIENCES INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Cassava Sciences, Inc. - SAVA

November 11, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Is the Stock Market Open on Election Day 2022? ↗

November 07, 2022

Investors are wondering if the stock market is open on Election Day this year as they seek out extra time to head to the polls!

Via InvestorPlace

Cassava Sciences Has a Big Warning for SAVA Stock Short Sellers ↗

November 07, 2022

SAVA stock is in the green after reporting earnings. The company also filed a lawsuit against short sellers, alleging misleading statements.

Via InvestorPlace

Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates

November 07, 2022

From Cassava Sciences, Inc.

Via GlobeNewswire

What the Latest Controversy Really Means for SAVA Stock ↗

November 07, 2022

SAVA stock continues to be dogged by controversy, but the risk/reward proposition for this biotech largely remains the same.

Via InvestorPlace

Cassava Sciences Files Lawsuit Against Perpetrators of “Short and Distort” Campaign

November 03, 2022

From Cassava Sciences, Inc.

Via GlobeNewswire

Why Is Cassava Sciences (SAVA) Stock Down 10% Today? ↗

November 02, 2022

SAVA stock is in the red after a piece from Probes Reporter accused Cassava of being involved with two undisclosed SEC investigations.

Via InvestorPlace

A New Study Makes Cassava Sciences Stock an Interesting Buy ↗

October 31, 2022

With the biotech firm moving forward with an open-label study of its Alzheimer's treatment simufilam, SAVA stock is one to watch.

Via InvestorPlace

Cassava Sciences Announces Expansion of Leadership Team

October 27, 2022

From Cassava Sciences, Inc.

Via GlobeNewswire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 24, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Short Interest Sector Focus: Healthcare Sector ↗

October 20, 2022

As of the close of business on Wednesday, 10/19, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

Alzheimer’s Pipeline of New Treatments Race to Improve Quality of Life for Patients

October 20, 2022

Palm Beach, FL – October 20, 2022 – FinancialNewsMedia.com News Commentary – Last year, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, (AD) which...

Via FinancialNewsMedia

CASSAVA SCIENCES INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Cassava Sciences, Inc. - SAVA

October 14, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

SAVA Stock Alert: Cassava Sciences Extends Trial ↗

October 13, 2022

SAVA stock is in focus after Cassava announced that it would begin an open-label study of its investigational Alzheimer's drug, simufilam.

Via InvestorPlace

Cassava Sciences Announces Initiation of an Open-label Extension Study

October 13, 2022

From Cassava Sciences, Inc.

Via GlobeNewswire

Don’t Let Misconduct Allegations Cloud Your Perception of SAVA Stock ↗

October 11, 2022

It's easy to get mired in the controversy surrounding Cassava Sciences, but distracted SAVA stock traders might miss an opportunity.

Via InvestorPlace

3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up

October 06, 2022

Here is a look at three names that buy-and-hold investors may want to consider as the race to find a cure for Alzheimer's disease accelerates

Via MarketBeat

Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session ↗

October 06, 2022

Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...

Via Benzinga

2 Signals to Watch Before Buying SAVA Stock ↗

October 05, 2022

SAVA stock got ahead of itself in September, but if it continues to pull back, a solid entry point could emerge for this risky biotech play.

Via InvestorPlace

EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank? ↗

October 04, 2022

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

$100 Invested In Cassava Sciences 15 Years Ago Would Be Worth This Much Today ↗

October 03, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 15 years by 3.29% on an annualized basis producing an average annual return of 9.08%. Currently, Cassava Sciences has a market...

Via Benzinga

$1000 Invested In This Stock 20 Years Ago Would Be Worth $10,000 Today ↗

September 30, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 20 years by 4.23% on an annualized basis producing an average annual return of 12.02%. Currently, Cassava Sciences has a market...

Via Benzinga

How High Can SAVA Stock Go Once the Controversy Clears? ↗

September 30, 2022

If a reproduced SEC letter concerning Cassava Sciences' clearance is legit, SAVA stock could head much higher.

Via InvestorPlace

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.